Professor of oncology at the Roswell Park Cancer Institute
Mikhail (Misha) V. Blagosklonny graduated with an MD and PhD from First
Pavlov State Medical University of St. Petersburg, Russia. Dr. Mikhail
V. Blagosklonny subsequently relocated to the United States, where he
was awarded the prestigious Fogarty Fellowship from the National
Institutes of Health. During his fellowship in Leonard Neckers’
laboratory at the National Cancer Institute (NCI), he was a co-author of
18 publications on diverse biomedical topics, including targeting
HSP90, p53, Bcl2, Erb2, and Raf-1. He also was the last author on a
clinical phase I/II trial paper.
Visit website: https://www.roswellpark.org/mikhail-blagosklonny
See also: Roswell Park Comprehensive Cancer Center - First center in USA focused on cancer research and treatment
Mikhail Blagosklonny is also referenced in the following:
Mikhail Blagosklonny News
DNA-damage or telomere shortening may not cause normal ageing
EurekAlert! - 08-Jun-2021
Rapamycin fails to extend lifespan in telomerase-deficient mice, while improving lifespan by 39% in normal miceRead more...
Rapamycin shows a sixty percent life expectancy increase in mice model
Aging - 04-Oct-2019
Detailed history and review of current understanding of Rapamycin and longevityRead more...
Everyday drugs could give extra years of life
New Scientist - 01-Oct-2014
Rapamycin in mice The study was published in the Diabetes, Obesity and Metabolism journal.Read more...